# Predictive Value of Glycemic Parameters Measured With the FSL Pro iQ During ACS

> **NCT06014112** · NA · RECRUITING · sponsor: **University Hospital, Montpellier** · enrollment: 850 (estimated)

## Conditions studied

- Acute Coronary Syndrome
- Continuous Glucose Measurement
- Glycemic Variability
- Cardiovascular Event

## Interventions

- **DEVICE:** Freestyle Libre Pro iQ

## Key facts

- **NCT ID:** NCT06014112
- **Lead sponsor:** University Hospital, Montpellier
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-11-06
- **Primary completion:** 2028-05-06
- **Final completion:** 2028-05-06
- **Target enrollment:** 850 (ESTIMATED)
- **Last updated:** 2025-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06014112

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06014112, "Predictive Value of Glycemic Parameters Measured With the FSL Pro iQ During ACS". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT06014112. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*